Quantcast
Channel: Health Care RSS Feed
Viewing all articles
Browse latest Browse all 24668

At high-stakes table, growing Peninsula biotech antes up with 'fatty-liver' drug

$
0
0
Even before morbidly overweight people lose pounds through gastric bypass surgery — within only a couple days of the procedure — they shed obesity-related diabetes. Tagging the phenomenon to a specific hormone led to the founding 10 years ago of NGM Biopharmaceuticals Inc. The company developed its own version of the hormone, engineering out the hormone's connection to a higher risk of liver cancer. Trending: Meet the 130 Best Places to Work in the Bay Area 2017 But instead of pushing forward…

Viewing all articles
Browse latest Browse all 24668

Trending Articles